Cargando…
TOR1B: a predictor of bone metastasis in breast cancer patients
Recent therapeutic advances in breast cancer (BC) have improved survival outcomes; however, the prognosis for patients with bone metastasis (BM) remains poor. Hence, novel clinical biomarkers are needed to accurately predict BC BM as well as to promote personalized medicine. Here, we discovered a no...
Autores principales: | Nguyen, Minh Nam, Akter, Salima, Akhter, Hajara, Ansary, Shahina, Han, Sunhee, Shin, Yoonhwa, Ha, Joohun, Kang, Insug, Kim, Sung Soo, Choi, Tae Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883392/ https://www.ncbi.nlm.nih.gov/pubmed/36707670 http://dx.doi.org/10.1038/s41598-023-28140-y |
Ejemplares similares
-
Correlation between Oxidative Stress and Transforming Growth Factor-Beta in Cancers
por: Chung, Jinwook, et al.
Publicado: (2021) -
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
por: Akter, Salima, et al.
Publicado: (2022) -
Diagnosis by Volatile Organic Compounds in Exhaled Breath from Patients with Gastric and Colorectal Cancers
por: Chung, Jinwook, et al.
Publicado: (2022) -
Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease
por: Shin, Yoonhwa, et al.
Publicado: (2023) -
The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production
por: Ju, Songhyun, et al.
Publicado: (2023)